Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.31B | 8.83B | 7.62B | 6.66B | 4.80B | 3.59B |
Gross Profit | 4.12B | 1.87B | 4.10B | 3.81B | 2.80B | 1.84B |
EBITDA | 1.74B | 1.63B | 1.44B | 1.18B | 900.18M | 649.19M |
Net Income | 1.16B | 1.09B | 961.74M | 819.77M | 632.62M | 384.49M |
Balance Sheet | ||||||
Total Assets | 0.00 | 9.93B | 7.86B | 5.68B | 4.62B | 3.03B |
Cash, Cash Equivalents and Short-Term Investments | 1.97B | 1.97B | 2.07B | 1.53B | 1.05B | 483.91M |
Total Debt | 0.00 | 754.52M | 263.46M | 135.27M | 206.79M | 355.69M |
Total Liabilities | -6.19B | 3.74B | 2.81B | 1.64B | 1.43B | 971.86M |
Stockholders Equity | 6.19B | 6.19B | 5.05B | 4.05B | 3.18B | 2.06B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.01B | 1.15B | 763.31M | 505.42M | 424.61M |
Operating Cash Flow | 0.00 | 1.11B | 1.17B | 841.04M | 701.17M | 560.91M |
Investing Cash Flow | 0.00 | -1.13B | -637.68M | -593.61M | -627.03M | -256.10M |
Financing Cash Flow | 0.00 | 276.46M | 10.54M | -107.37M | -235.63M | -276.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | ₹26.47B | 15.81 | ― | 1.24% | 4.85% | 1.23% | |
67 Neutral | ₹24.25B | 20.15 | ― | 0.44% | 19.50% | 18.47% | |
65 Neutral | ₹21.92B | 40.53 | ― | ― | 358.71% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ₹16.14B | 72.43 | ― | 0.48% | 4.89% | -62.30% | |
56 Neutral | ₹14.32B | 33.32 | ― | 0.94% | 11.08% | -3.08% | |
52 Neutral | ₹37.41B | 534.48 | ― | 0.24% | 8.64% | ― |
Saksoft Limited announced the approval of its unaudited financial results for the quarter ending June 30, 2025, with no adverse remarks from auditors. Additionally, the company approved a Scheme of Amalgamation with Augmento Labs Private Limited, subject to necessary approvals, which may enhance its market position and operational capabilities.